About Us
Current Events
Past Events
Video Gallery
Policy & Reports
Media Coverage
Contact Us
14th Annual BioPharma & Healthcare Summit, September 4, 2020 - Virtual Edition
Video Gallery
  • Welcome address by Karun Rishi, President, USAIC
  • Opening Address by Andrew Plump

    Opening comments Dr Andrew Plump, President of R&D, Takeda Pharmaceuticals

  • COVID-19 panel: Where are we now? Where are we going?

    Panelists: Dr. Barry Bloom, Professor & former Dean, Harvard School of Public Health; Dr. George Yancopoulos, Co-Founder, President & CSO, Regeneron; Kiran Mazumdar-Shaw, Executive Chairperson, Biocon; Dr. Rajeev Venkayya, President of the Global Vaccine Business Unit, Takeda; Dr. Richard Hatchett, CEO, Coalition for Epidemic Preparedness Innovations (CEPI)
    Moderator: Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

  • India Regulatory Update

    Dr. Mandeep Bhandari, Joint Secretary, Ministry of Health & Family Welfare, India; Dr. V G Somani, Drug Controller General of India, Central Drug Control Organization
    Moderator: Muna Bhanji, Senior Vice President,  Merck & Co.

  • Fireside Chat with Kenneth Frazier moderated by Stelios Papadopoulos

    Kenneth Frazier, Chairman of the Board and Chief Executive Officer, Merck & Co.
    Dr. Stelios Papadopoulos, Chairman of the Board, Biogen

  • India Innovation Landscape Panel

    Panelists: Amitabh Kant, Chief Executive Officer, National Institution for Transforming India (NITI); Hari Bhartia, Founder & Co-Chairman, Jubilant Bhartia Group; Dr. K. Vijay Raghavan, Principal Scientific Advisor, Government of India; Dr. Naresh Trehan, Chairman, Medanta - the Medicity
    Moderator: Sanat Chattopadhyay, President, Merck Manufacturing Division; Merck & Co.

  • Oncology panel discussion: Changing landscape- COVID learnings and the promise of new technologies

    Panelists: Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic; Dr. Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute; Dr. Philip Larsen, Global Head of Research, Bayer AG; Rehan Verjee, President, EMD Serono; Dr. Tony Ho, Head of Research and Development, CRISPR Therapeutics
    Moderator: Dr. Raju Kucherlapati, Professor of Genetics, Harvard Medical School

  • Industry & Investment Outlook Panel Discussion

    Panelists: Christopher Viehbacher, Managing Partner, Gurnet Point Capital; Daphne Zohar, Founder & CEO, PureTech Health; Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University; Dr. Stelios Papadopoulos, Chairman, Biogen
    Moderator: Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals

  • Rare Diseases panel: No longer forgotten; but more to be achieved

    Panelists: Dr. Alfred Sandrock, Executive Vice President, Research & Development, Biogen; Dr. Daniel Curran, Head of the Rare Diseases Therapeutic Area Unit, Takeda; Dr. David Meeker, Chairman & CEO , Rhythm Pharmaceuticals; Dr. John Orloff, Head of Research & Development, Alexion; Matt Wilsey, Co-Founder & Chairman, Grace Science Foundation
    Moderator: Dr. Steve Uden, Co-Founder, Rallybio

  • Fireside Chat with Roy Vagelos moderated by Mathai Mammen

    Dr. Roy Vagelos, Chairman of the Board, Regeneron Pharmaceuticals
    Dr. Mathai Mammen, Global Head of Janssen Research & Development, Johnson & Johnson

  • Digital & Data Science in Healthcare Panel: Pragmatic Insights from the Real-World

    Panelists: Dr. Anne Heatherington, Head of Data Sciences Institute, Takeda Pharmaceuticals; Arpa GarayPresident, Global Pharmaceuticals, Commercial Analytics, Merck & Co.; Dr. Maya Said, Chief Executive Officer, Outcomes4Me; Dr. Najat Khan, Chief Operating Officer, Janssen R&D Data Sciences, Johnson & Johnson; Nina Kjellson, General Partner, Canaan
    Moderator: Sastry Chilukuri, President, Acorn AI- Medidata

  • R&D Strategies and Trends Panel: Innovation- The Big I

    Panelists: Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals; Dr. David Reese, Executive Vice President, Research and Development, Amgen; Dr. Hal Barron, Chief Scientific Officer and President R&D, GlaxoSmithKline; Dr. Mathai Mammen, Global Head of Janssen Research & Development, Johnson & Johnson
    Moderator: Dr. Martin Mackay, Co-Founder, Rallybio

  • Closing Remarks by Andrew Plump, President of R&D, Takeda
© 2007 - USA India Chamber of Commerce Home | About us | Policy | Events | Photo Gallery | Awards | Membership | Media Coverage | Legal | Contact us